Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: A meta-analysis

Diseases of the Esophagus

Volumn 25, Issue 6, 2012, Pages 520-526

  Zhao, J ^a   Li, L ^b   Wei, S ^c   Gao, Y ^b   Chen, Y ^d   Wang, G ^a   Wu, Z ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cyclin D1; Esophageal neoplasm; Meta analysis; Prognosis

Indexed keywords

CYCLIN D1;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CYCLIN D1; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; ODDS RATIO; PROGNOSIS;

EID: 84865039256     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01278.x     Document Type: Article

References (32)

1. Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Kamangar F, Dores G M, Anderson W F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-50.
3. Matsushime H, Roussel M F, Ashmun R A, Sherr C J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65: 701-13.
4. Hunter T, Pines J. Cyclins and cancer. Cell 1991; 66: 1071-4.
5. Zhou P, Jiang W, Zhang Y J etal. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 1995; 11: 571-80.
6. Parmar M K, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-34.
7. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 8: 15-17.
8. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
9. Mathew R, Arora S, Khanna R, Mathur M, Shukla N K, Ralhan R. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Eur J Cancer 2002; 38: 832-41.
10. Shinohara M, Aoki T, Sato S etal. Cell cycle-regulated factors in esophageal cancer. Dis Esophagus 2002; 15: 149-54.
11. Ikeguchi M, Sakatani T, Ueta T, Kaibara N. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2001; 127: 531-6.
12. Toyoda H, Nakamura T, Shinoda M etal. Cyclin D1 expression is useful as a prognostic indicator for advanced esophageal carcinomas, but not for superficial tumors. Dig Dis Sci 2000; 45: 864-9.
13. Nagasawa S, Onda M, Sasajima K etal. Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol 2001; 78: 208-14.
14. Güner D, Sturm I, Hemmati P etal. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 2003; 103: 445-54.
15. Kuwahara M, Hirai T, Yoshida K etal. p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer. Dis Esophagus 1999; 12: 116-19.
16. Anayama T, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 1998; 79: 439-43.
17. Ikeda G, Isaji S, Chandra B, Watanabe M, Kawarada Y. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 1999; 86: 1396-405.
18. Sarbia M, Stahl M, Fink U etal. Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer 1999; 84: 86-91.
19. Masayuki I, Yutaka S, Hiroko I etal. Prognostic significance of cyclinD1 and E-cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 2001; 192: 708-18.
20. Fukuchi M, Fukai Y, Kimura H etal. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol 2006; 29: 329-34.
21. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995; 146: 1161-9.
22. Lin Y C, Wu M Y, Li D R, Wu X Y, Zheng R M. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10: 3235-9.
23. Kagawa Y, Yoshida K, Hirai T, Toge T. Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas. Dis Esophagus 2000; 13: 179-84.
24. Bizari L, Borim A A, Leite K R etal. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet 2006; 165: 41-50.
25. Qi Z L, Huo X, Xu X J etal. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Exp Oncol 2006; 28: 235-40.
26. Sunpaweravong P, Sunpaweravong S, Puttawibul P etal. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2005; 131: 111-19.
27. Sun A, Li D, Mu D, Li H, Luo J. Expressions of cyclin D1 and Ki-67 and their correlation with prognosis in esophageal squamous cell carcinoma. Chin J Cancer Prev Treat 2008; 15: 276-79. (in Chinese).
28. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 1998; 77: 92-7.
29. Malats N, Bustos A, Nascimento C M etal. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 2005; 6: 678-86.
30. Matsushime H, Roussel M F, Ashmun R A, Sherr C J. Colony-stimulating factor 1regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65: 701-13.
31. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991; 65: 691-9.
32. Shamma A, Doki Y, Shiozaki H etal. Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 2000; 16: 261-6.